A detailed history of Hollencrest Capital Management transactions in Medtronic PLC stock. As of the latest transaction made, Hollencrest Capital Management holds 737 shares of MDT stock, worth $58,982. This represents 0.0% of its overall portfolio holdings.

Number of Shares
737
Previous 512 43.95%
Holding current value
$58,982
Previous $40,000 65.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$76.84 - $91.03 $17,289 - $20,481
225 Added 43.95%
737 $66,000
Q2 2024

Aug 12, 2024

SELL
$78.71 - $87.02 $4,958 - $5,482
-63 Reduced 10.96%
512 $40,000
Q4 2023

Feb 14, 2024

BUY
$69.43 - $83.43 $28,882 - $34,706
416 Added 261.64%
575 $47,000
Q2 2023

Aug 10, 2023

SELL
$79.47 - $91.38 $13,907 - $15,991
-175 Reduced 52.4%
159 $14,000
Q1 2023

May 16, 2023

SELL
$76.72 - $87.58 $567,728 - $648,092
-7,400 Reduced 95.68%
334 $26,000
Q4 2022

Feb 06, 2023

BUY
$76.18 - $87.74 $589,176 - $678,581
7,734 New
7,734 $601,000
Q3 2022

Oct 27, 2022

BUY
$80.75 - $95.31 $8,236 - $9,721
102 Added 1.33%
7,782 $629,000
Q2 2022

Jul 21, 2022

SELL
$87.4 - $113.09 $48,856 - $63,217
-559 Reduced 6.78%
7,680 $689,000
Q1 2022

Apr 18, 2022

SELL
$100.58 - $112.38 $2,112 - $2,359
-21 Reduced 0.25%
8,239 $914,000
Q4 2021

Jan 07, 2022

SELL
$99.53 - $127.75 $36,328 - $46,628
-365 Reduced 4.23%
8,260 $855,000
Q2 2021

Jul 21, 2021

BUY
$118.19 - $131.5 $41,721 - $46,419
353 Added 4.27%
8,625 $1.07 Million
Q1 2021

Apr 29, 2021

BUY
$111.18 - $119.74 $252,156 - $271,570
2,268 Added 37.77%
8,272 $977,000
Q3 2020

Oct 13, 2020

BUY
$90.13 - $108.78 $14,781 - $17,839
164 Added 2.81%
6,004 $624,000
Q2 2020

Jul 16, 2020

BUY
$84.11 - $103.33 $491,202 - $603,447
5,840 New
5,840 $535,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $106B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.